Nat Habit lines up $15 Mn Series C round
By Abha Lohia ·
- Nat Habit sells natural skin and hair care products and has recently rebranded itself as Breathe Life, moving beyond its Ayurvedic roots
- The company is issuing 22.5 lakh Series C shares to raise about ₹142.6 crore, with Trident Growth Partners leading the round with ₹91 crore
- Funds go to expansion and brand building; after the round Trident holds roughly 11% and existing backer Bertelsmann about 17.5%
What happened
- Nat Habit is raising ₹142.6 crore in a Series C round.
- Trident Growth Partners puts in ₹91 crore as lead.
- Bertelsmann adds ₹37 crore and Linklight Ventures ₹6.8 crore.
- Mirabilis, Firstport and Dharmayug Investments fill the rest.
Why it matters
- The money is meant for expansion and brand building.
- About ₹2.6 crore is set aside to reduce the employee stock option pool.
- The round values the firm at close to ₹800 crore by one estimate.
The business
- Nat Habit makes natural skin and hair care products.
- It started with an Ayurvedic positioning.
- It has now rebranded as Breathe Life, a wider lifestyle idea.
- It sells direct to consumers.
The founders
Who put in money
- Trident Growth Partners lead
- Bertelsmann existing investor
- Linklight Ventures investor
In numbers
₹142.6 CrRound size · 2026
Earlier rounds
- Series C of ₹142.6 crore, led by Trident Growth Partners
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a stock-market listing or a sale. Each step is larger than the last and asks for more proof.
- Series B/C: Series B, C, D and later rounds are growth rounds: large cheques that help a startup with a proven model expand faster, enter new markets or move toward profit and a listing.
More on Nat Habit
Same day
- AL
Astrogate Labs · Partnership · 9 October 2026Astrogate Labs ties up with Spacebeam on laser links
- AW
Awfis · Stake sale · 9 October 2026 · ₹47.04 CrPeak XV sells 2.68% of Awfis - FC
Fusion CX · IPO · 9 October 2026 · ₹702 CrFusion CX sets ₹275-289 price band for ₹702 Cr IPO - GE
Genetidoc · Launch · 9 October 2026Genetidoc launches online forum for rare diseases - GR
Gramiyaa · Funding · 9 October 2026 · ₹18.65 CrGramiyaa raises ₹18.65 Cr Series A - IN
Instamart · News · 9 October 2026Instamart eyes private labels beyond food
Is this Nat Habit? Get your “Featured on StopDown” badge →